ODYSSEY THERAPEUTICS, INC.

Profile

Company Names

ODYSSEY THERAPEUTICS, INC.

Addresses

51 SLEEPER STREET, BOSTON, MA 02210

51 SLEEPER STREET, SUITE 800, BOSTON, MA 02210

301 BINNEY STREET, CAMBRIDGE, MA 02142

266 MAIN STREET, BUILDING 2, SUITE 11, MEDFIELD, MA 02052

Phone Numbers

617-865-9628
(212) 841-1000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2021

State Incorporated:

DELAWARE

Total Amount Raised:

$590,874,970.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-06-16 
$214,025,200.00 
$214,025,200.00 
$0.00 
Equity 
3
2023-10-25 
$117,210,000.00 
$121,080,000.00 
$3,870,000.00 
Equity 
2
2022-05-13 
$168,009,933.00 
$174,909,939.00 
$6,900,006.00 
Equity 
1
2021-08-30 
$91,629,837.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
 
BAUM 
DIRECTOR
METHYLGENE INC.   |  ODYSSEY THERAPEUTICS, INC.   |  CROSSBOW THERAPEUTICS, INC.   |  TERREMOTO BIOSCIENCES, INC.
CHARLES 
M. 
BAUM 
DIRECTOR
POSEIDA THERAPEUTICS, INC.   |  ODYSSEY THERAPEUTICS, INC.
CHUCK 
 
BAUM 
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
M. 
CHARLES 
BAUM 
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
JILL 
 
CARROLL 
DIRECTOR
VASCULOX, INC.   |  TIOMA THERAPEUTICS, INC.   |  ARCELLX, INC.   |  NKARTA, INC.   |  PANDION THERAPEUTICS HOLDCO LLC   |  ODYSSEY THERAPEUTICS, INC.   |  AVALYN PHARMA INC.   |  AIRNEXIS THERAPEUTICS, INC.
SHELLEY 
 
CHU 
DIRECTOR
KALIDEX PHARMACEUTICALS, INC.   |  ABINGWORTH BIOVENTURES VII LP   |  VENATORX PHARMACEUTICALS, INC.   |  IFM QUATTRO, INC.   |  IFM CINQUE, INC.   |  IFM CONTINUA, INC.   |  SCORPION THERAPEUTICS, INC.   |  ENLAZA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA   |  TRIANA BIOMEDICINES, INC.   |  SEISMIC THERAPEUTIC, INC.   |  ANTARES THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA, INC.   |  ODYSSEY THERAPEUTICS, INC.
GARY 
D 
GLICK 
EXECUTIVE OFFICER, DIRECTOR
IFM TRE, INC.   |  ODYSSEY THERAPEUTICS, INC.
GARY 
D. 
GLICK 
EXECUTIVE OFFICER, DIRECTOR
LYCERA CORP   |  ODYSSEY THERAPEUTICS, INC.
CARL 
 
GORDON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  AMNIS CORP   |  IGENICA INC   |  ACCELERON PHARMA INC   |  ARAGON PHARMACEUTICALS, INC.   |  GOOD START GENETICS, INC.   |  ARSANIS, INC.   |  SINGULEX INC   |  SELECTA BIOSCIENCES INC   |  IGENICA BIOTHERAPEUTICS, INC   |  COMPASS THERAPEUTICS LLC   |  ADICET BIO, INC.   |  INTELLIA THERAPEUTICS, INC.   |  ALECTOR LLC   |  GEMINI THERAPEUTICS, INC.   |  SPRINGWORKS THERAPEUTICS, LLC   |  PREVAIL THERAPEUTICS INC.   |  THESEUS PHARMACEUTICALS, INC.   |  TP THERAPEUTICS, INC.   |  KUMQUAT BIOSCIENCES INC   |  PASSAGE BIO, INC.   |  KEROS THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  BLOSSOMHILL THERAPEUTICS, INC.   |  SCRIBE THERAPEUTICS, INC.   |  GARUDA THERAPEUTICS, INC.   |  ODYSSEY THERAPEUTICS, INC.   |  ALTEROME THERAPEUTICS, INC.   |  AVENZO THERAPEUTICS, INC.   |  MBX BIOSCIENCES, INC.   |  ARRIVENT BIOPHARMA, INC.   |  BELENOS BIOSCIENCES, INC.   |  LOMOND THERAPEUTICS HOLDINGS, INC.   |  STAR THERAPEUTICS LLC
JASON 
 
HAAS 
EXECUTIVE OFFICER
SYROS PHARMACEUTICALS, INC.   |  ODYSSEY THERAPEUTICS, INC.
PAULINA 
 
HILL 
DIRECTOR
FARADAY PHARMACEUTICALS, INC.   |  NEXTPOINT THERAPEUTICS, INC.   |  AVILAR THERAPEUTICS, INC.   |  JW CELTICS INVESTMENT CORP.   |  NORMUNITY HOLDING COMPANY, LLC   |  ODYSSEY THERAPEUTICS, INC.
LORENCE 
 
KIM 
DIRECTOR
SERES HEALTH, INC.   |  MODERNA LLC   |  MODERNA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  ASCENTA CAPITAL SPV I, L.P.   |  ASCENTA CAPITAL PROJECT TURING SPV, L.P.   |  ODYSSEY THERAPEUTICS, INC.   |  ASCENTA CAPITAL PROJECT ARGOS SPV, L.P.   |  ASCENTA CAPITAL FUND I, L.P.   |  ASCENTA CAPITAL PROJECT IKIGAI SPV, L.P.   |  ASCENTA CAPITAL PROJECT HENRI SPV, L.P.   |  TRIANA BIOMEDICINES, INC.
JEFFREY 
 
LEIDEN 
DIRECTOR
LYCERA CORP   |  CATABASIS PHARMACEUTICALS INC   |  TYRX PHARMA INC   |  BIOLEX THERAPEUTICS, INC.   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  CASANA CARE, INC.   |  ODYSSEY THERAPEUTICS, INC.
NAN 
 
LI 
DIRECTOR
ZY THERAPEUTICS INC.   |  HATFIELD, INC.   |  ITERATIVE SCOPES, INC.   |  AI FLEET INC.   |  DIMENSION CAPITAL I, L.P.   |  FIVEONEFOUR LABS INC.   |  ODYSSEY THERAPEUTICS, INC.
CAROLYN 
 
NG 
DIRECTOR
OBSIDIAN THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  NUVAIRA, INC.   |  ODYSSEY THERAPEUTICS, INC.
VALERIE 
 
ODEGARD 
DIRECTOR
ODYSSEY THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.
KSENIJA 
 
PAVLETIC 
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
IAN 
 
SMITH 
DIRECTOR
CARGURUS LLC   |  CROSSHAIR EXPLORATION + MINING CORP   |  YELLOWHEAD MINING INC.   |  MAX RESOURCE CORP.   |  FUNKY EYES INTERNATIONAL, INC.   |  XAPO HOLDINGS LTD   |  CATHEDRAL LAKE II, LTD.   |  CATHEDRAL LAKE III, LTD.   |  CATHEDRAL LAKE CLO 2013, LTD.   |  FOODTRUCKR, LLC   |  AURORA INNOVATION, INC.   |  CARGURUS, INC.   |  VIACYTE INC.   |  SANATANA RESOURCES INC   |  SOLID BIOSCIENCES INC.   |  AURORA INNOVATION, INC.   |  ODYSSEY THERAPEUTICS, INC.   |  RIVUS PHARMACEUTICALS, INC.
LAN 
F. 
SMITH 
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
NIA 
 
TATSIS 
DIRECTOR
ODYSSEY THERAPEUTICS, INC.
TIMOTHY 
 
WALBERT 
DIRECTOR
ODYSSEY THERAPEUTICS, INC.   |  MIRUM PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-04
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-06-16 
2024-08-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2023-12-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-25 
2022-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-13 
2021-10-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#